Related Experiment Videos
Roundtable discussion: Part III--Hypertension management in health plans
Managed Care Interface
|February 24, 2001
Insights
Managed care plans target hypertension through disease management and noncompliance strategies. Pharmacoeconomic data informs formulary decisions for hypertension medications.
Area of Science:
- Cardiovascular Medicine
- Health Services Research
- Pharmacoeconomics
Background:
- Hypertension management is complex within managed care settings.
- Effective strategies are needed to address patient noncompliance.
- Pharmacoeconomic considerations influence medication access and formulary placement.
Purpose of the Study:
- To explore managed care plan approaches to hypertension management.
- To understand strategies for improving patient adherence.
- To examine the role of pharmacoeconomics in formulary decisions.
Main Methods:
- Roundtable discussion with managed care plan representatives.
- Qualitative analysis of participant insights.
- Focus on disease management targeting, noncompliance strategies, and pharmacoeconomic utilization.
Main Results:
- Managed care plans employ diverse disease management targets for hypertension.
- Various strategies are utilized to combat patient noncompliance.
- Pharmacoeconomic information significantly impacts drug formulary decision-making.
Conclusions:
- Managed care organizations utilize multifaceted approaches for hypertension control.
- Addressing noncompliance is a key focus in hypertension management.
- Pharmacoeconomic evaluations are integral to formulary development in managed care.
Abstract:
In the final section of the roundtable discussion, participants describe how their individual managed care plans approach hypertension from the standpoints of disease management targeting, strategies to combat noncompliance, and how these plans utilize pharmacoeconomic information in drug formulary decision making.